| 000 | 01127 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516013629.0 | ||
| 264 | 0 | _c20110331 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1744-7674 | ||
| 024 | 7 |
_a10.1517/13543776.2011.539204 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGilbert, Adam M | |
| 245 | 0 | 0 |
_aAdvances in the development of novel aggrecanase inhibitors. _h[electronic resource] |
| 260 |
_bExpert opinion on therapeutic patents _cJan 2011 |
||
| 300 |
_a1-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aEndopeptidases _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 |
_aOsteoarthritis _xdrug therapy |
| 650 | 0 | 4 | _aPatents as Topic |
| 650 | 0 | 4 |
_aProtease Inhibitors _xchemistry |
| 700 | 1 | _aBikker, Jack A | |
| 700 | 1 | _aO'Neil, Steven V | |
| 773 | 0 |
_tExpert opinion on therapeutic patents _gvol. 21 _gno. 1 _gp. 1-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543776.2011.539204 _zAvailable from publisher's website |
| 999 |
_c20403470 _d20403470 |
||